Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Biomedicines|September 28, 2023
Blood-Biomarkers for Glucose Metabolism in Preterm InfantsMia O Bjerager, Bo M Hansen, Frederik Sørensen, et al.
Critical Care (London, England)|January 23, 2024
Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trialLaust E R Obling, Rasmus P Beske, Martin A S Meyer, et al.
Science (New York, N.Y.)|March 26, 2011
The Buttermilk Creek complex and the origins of Clovis at the Debra L. Friedkin site, TexasMichael R Waters, Steven L Forman, Thomas A Jennings, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2020
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trialNicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Diabetes, Obesity & Metabolism|October 17, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trialSigne Foghsgaard, Louise Vedtofte, Emilie S Andersen, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|January 10, 2018
Noninvasive measurement of reepithelialization and microvascularity of suction-blister wounds with benchmarking to histologyHeidi F Larsen, Malin G Ahlström, Lise M R Gjerdrum, et al.
Systematic Reviews|April 18, 2018
Does information from ClinicalTrials.gov increase transparency and reduce bias? Results from a five-report case seriesGaelen P Adam, Stacey Springs, Thomas Trikalinos, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trialMads M Helsted, Christiane Fonnesbech-Wulff, Nina L Schaltz, et al.
European Journal of Endocrinology|April 16, 2025
High-intensity interval training improves insulin sensitivity in individuals with prediabetesPernille Mensberg, Clarissa Frandsen, Christian S Carl, et al.
Eclinicalmedicine|March 2, 2026
Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trialCasper K Nielsen, Thorir G Pálsson, Julie L Forman, et al.
Pageof 27